spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

2nd Annual Clinical Trial Supply East Asia

Clinical Trial Supply East Asia 2017

6-7 December 2017
Seoul, South Korea

This is the only event focusing Clinical Trials Supply in Korea. This event focuses on providing discussions to achieve efficient and seamless clinical supply for trials, as well as providing an In-depth overview into the key regulatory challenges faced by companies in the East Asia region. This is a unique event encompassing discussions around strategies to ensure smooth clinical trial supply chain

In addition to this, the event will look at a the newest innovations in clinical trial supply at an event that will bring together key professionals across different companies and combine the knowledge of both small, emerging the perfect opportunity for attendees to discuss with competitors, service providers and companies of different sizes the best ways to implement their strategy

Why This Event – Why Now?

The landscape of clinical trials in Asia is changing. Many of the global pharmaceutical companies may have first decided to move to Asia for the patient pool and cheaper cost. However, the whole spotlight in Asia is now impacting the pharmaceutical sector rather than just the mere clinical trials industry. Companies need to set their strategic sights on a future world where Asia is not just a market for the pharma industry, but could make a key contribution to drug discoveries as well.
 
Why CTS East Asia?

Asia now has more clinical trials than any other region in the world. Through research with suppliers there is some disagreement over whether the local market is growing in terms of companies, however no dispute at all in the number of trials happening in the region.

Why South Korea?

Despite much clinical activity, and certain evidence of growth in pharmaceutical industry in Asia, there are no clear signs of a compelling industry ‘cluster’ as seen in USA and Europe. Although, most countries in the region are making progress, and often with the support of the Government, few have reached the level of maturity necessary to be seen as a cluster.

For more information click here http://www.arena-international.com/ctseastasia/
phone +44 (0)207 936 6400
email events@arena-international.com
web www.arena-international.com/ctseastasia/
email Seoul, South Korea
 
Print this page
Send to a friend
   
spacer
Industry Events

Cell Line Development and Engineering

23-25 April 2018, RAI, Amsterdam

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of T3_events_97 on Samedan Banner of BIO_Europe_Events_102 on Samedan

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>


News and Press Releases

York Health Economics Consortium offers an updated training event

Health economics evidence is a key element in much health services research and particularly in health technology assessments, including submissions for NICE single technology appraisals. Identifying economic evidence to inform submissions involves searches in a range of databases and uses a variety of strategies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement